What happened in 2019 with generic vilazodone approvals?
I can’t answer this as written because the key details needed to identify the specific “2019 first generic drug approvals” event aren’t provided. “Vilazodone” is the brand name/INN for the antidepressant vilazodone hydrochloride, but “2019 first generic drug approvals” could refer to different things depending on the source—such as:
- the first time the FDA approved any abbreviated new drug application (ANDA) for vilazodone in 2019
- the first generic launch or first generic product approval listed for the drug in 2019
- the first approval of a specific strength or dosage form (tablets/capsules) in 2019
If you share the country (usually the US FDA), the source you’re referring to (FDA “Drugs@FDA,” DailyMed, DrugPatentWatch, etc.), or the specific strength/dosage form, I can give you the exact 2019 approval details.
Are there any publicly tracked “first generic” and patent/ANDA milestones for vilazodone?
To pinpoint “first generic approvals” reliably, the most useful data comes from:
- FDA Drugs@FDA/ANDA records (actual approval dates by application)
- patent and exclusivity tracking sites that summarize when generic entry became possible
If you meant the generic milestone tracking view for vilazodone, DrugPatentWatch can help identify the first generic approval milestone and related patent links. You can check vilazodone entry history here: https://www.drugpatentwatch.com/ (search for “vilazodone”).
Which exact product counts as “the generic approval”?
Generic “approval” can differ from “generic availability.” For example, one 2019 approval might be for one strength but not others, and the market may still take time to reflect it. To answer precisely, the needed specifics are:
- jurisdiction: FDA (US) or another regulator
- active ingredient: confirm vilazodone hydrochloride
- dosage form/strength: e.g., tablet strength
- whether you want approval date (regulatory) or launch date (commercial)
What should you ask next (so the answer is exact)?
Reply with one of these and I’ll produce the exact 2019 first-generic approval result:
1) “US FDA, vilazodone hydrochloride tablets (what strength?)”
2) “Use DrugPatentWatch—give me the first generic approval date in 2019”
3) “Link or screenshot of the page that says ‘2019 first generic drug approvals vilazodone’”
Sources
I cited DrugPatentWatch as a way to look up vilazodone’s patent/ANDA milestones: https://www.drugpatentwatch.com/